THERAPY

Jan 23 2025HEALTH

Neuropathy Risk: A Year with Chemo Drugs

Did you know that chemotherapy can sometimes cause nerve damage in your hands and feet? This is called peripheral neuropathy, and it can really affect how patients feel and live their lives. A big study called the MiroCIP study looked into this. They checked out two types of chemo drugs: oxaliplatin

reading time less than a minute
Jan 23 2025HEALTH

Combining Compression and Exercise to Beat Chemo's Nerve Numbness

Ever wondered if squeezing and moving could help beat the nerve pain from breast cancer chemo? Researchers did, and they found out something interesting. They gathered people who had numbness in their hands and feet from chemo, and split them into two groups. One group tried combining squeezing (com

reading time less than a minute
Jan 22 2025SCIENCE

Unlocking the Power of UGT51: A New Way to Produce Rare Ginsenoside Rh2

You might have heard of ginsenoside Rh2, a compound with amazing health benefits. It can help fight certain cancers, reduce inflammation, and even tackle diabetes. But how do we make more of this wonder substance? Scientists have been looking into an enzyme called UGT51 from yeast, which plays a key

reading time less than a minute
Jan 22 2025HEALTH

Boosting TNBC Treatment: A Innovative Hydrogel Combats CAR-T Cell Challenges

Triple-negative breast cancer (TNBC) is tough to tackle due to issues like poor blood vessels and high tumor cell load. These problems make it hard for CAR-T cells, a type of immune cell therapy, to work well. Researchers found that when there are fewer CAR-T cells compared to tumor cells, the immun

reading time less than a minute
Jan 22 2025HEALTH

What's the Bleeding Risk After Heart Surgery with Meds?

Lots of people have both coronary artery disease and valvular heart disease. This means they often need two big surgeries: coronary artery bypass grafting and valve replacement or repair. After these procedures, doctors usually prescribe a mix of anticoagulants and antiplatelets to prevent blood clo

reading time less than a minute
Jan 19 2025HEALTH

Beating CAEBV with a New Weapon: Glycoprotein 350-Targeted T-Cell Therapy

Imagine living with a virus that never goes away. That's what people with Chronic Active Epstein-Barr Virus (CAEBV) infection experience. This infection, though rare, is serious. The Epstein-Barr virus (EBV) sticks around, causing symptoms and even life-threatening problems. Doctors are still figuri

reading time less than a minute
Jan 19 2025HEALTH

Sleep Therapy & Cancer Fatigue: A Closer Look

Cancer survivors often deal with something called cancer-related fatigue. It's one of the most common problems they face. Cognitive Behavioural Therapy for Insomnia (CBT-I) might help with this fatigue, but we're not sure exactly how it works. A group of researchers looked back at a study where peop

reading time less than a minute
Jan 19 2025HEALTH

Unlocking Cell and Gene Therapies: A Budget-Friendly Solution

You might have heard about cell and gene therapies (CGTs), which can treat rare and sometimes deadly diseases. The catch? They're expensive. People are worried that insurance companies might not want to pay for them. If you look at the big picture, the yearly cost of covering these therapies for eve

reading time less than a minute
Jan 19 2025HEALTH

Understanding NEC: A Gut Microbe Mystery

Necrotizing Enterocolitis, or NEC, is a serious health issue that mainly affects premature babies. It's like a fire in the belly, causing severe inflammation in the gut. Scientists are trying to understand how this happens by looking at it from different angles. They're combining insights from docto

reading time less than a minute
Jan 19 2025HEALTH

Rewriting Identity in Virtual Reality: A New Way to Battle Depression

Imagine stepping into a virtual world where you can explore the depths of your mind. That's what Mary did when she started using a digital platform called Explore Your Meanings, or EYME. This tool isn't just about gaming; it's designed to help people untangle their inner conflicts using virtual real

reading time less than a minute